Back to Search
Start Over
Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
- Source :
-
Matrix biology : journal of the International Society for Matrix Biology [Matrix Biol] 2013 Jun 24; Vol. 32 (5), pp. 228-33. Date of Electronic Publication: 2013 Mar 13. - Publication Year :
- 2013
-
Abstract
- Heparanase (Hpse) is an endo-β-d-glucuronidase that degrades the glycosaminoglycan heparan sulfate (HS) in basement membranes (BMs) to facilitate leukocyte migration into tissues. Heparanase activity also releases HS-bound growth factors from the extracellular matrix (ECM), a function that aids wound healing and angiogenesis. In disease states, the degradation of HS in BMs by heparanase is well recognized as an invasive property of metastatic cancer cells. Recent studies by our group, however, have identified unexpected new roles for heparanase and HS. First, we discovered that in Type 1 diabetes (T1D) (i) HS in the pancreatic islet BM acts as a barrier to invading cells and (ii) high levels of HS within the insulin-producing islet beta cells themselves are critical for beta cell survival, protecting the cells from free radical-mediated damage. Furthermore, catalytically active heparanase produced by autoreactive T cells and other insulitis mononuclear cells was shown to degrade intra-islet HS, increasing the susceptibility of islet beta cells to free radical damage and death. This totally novel molecular explanation for the onset of T1D diabetes opens up new therapeutic approaches for preventing disease progression. Indeed, administration of the heparanase inhibitor, PI-88, dramatically reduced T1D incidence in diabetes-prone NOD mice, preserved islet beta cell HS and reduced islet inflammation. Second, in parallel studies it has been shown that heparanase and HS can be transported to the nucleus of cells where they impact directly or indirectly on gene transcription. Based on ChIP-on-chip studies heparanase was found to interact with the promoters and transcribed regions of several hundred genes and micro-RNAs in activated Jurkat T cells and up-regulate transcription, with many of the target genes/micro-RNAs being involved in T cell differentiation. At the molecular level, nuclear heparanase appears to regulate histone 3 lysine 4 (H3K4) methylation by influencing the recruitment of demethylases to transcriptionally active genes. These studies have unveiled new functions for heparanase produced by T lymphocytes, with the enzyme mediating unexpected intracellular effects on T cell differentiation and insulin-producing beta cell survival in T cell-dependent autoimmune T1D.<br /> (Crown Copyright © 2013. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Cell Proliferation
Diabetes Mellitus, Type 1 drug therapy
Diabetes Mellitus, Type 1 immunology
Diabetes Mellitus, Type 1 pathology
Enzyme Inhibitors pharmacology
Extracellular Matrix chemistry
Extracellular Matrix immunology
Extracellular Matrix metabolism
Free Radicals antagonists & inhibitors
Free Radicals metabolism
Gene Expression Regulation immunology
Glucuronidase genetics
Heparitin Sulfate immunology
Humans
Islets of Langerhans drug effects
Islets of Langerhans immunology
Islets of Langerhans pathology
Mice
Oligosaccharides pharmacology
Signal Transduction
T-Lymphocytes drug effects
T-Lymphocytes immunology
T-Lymphocytes pathology
Diabetes Mellitus, Type 1 enzymology
Glucuronidase metabolism
Heparitin Sulfate biosynthesis
Islets of Langerhans enzymology
Subjects
Details
- Language :
- English
- ISSN :
- 1569-1802
- Volume :
- 32
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Matrix biology : journal of the International Society for Matrix Biology
- Publication Type :
- Academic Journal
- Accession number :
- 23499527
- Full Text :
- https://doi.org/10.1016/j.matbio.2013.02.007